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Abstract  
Ochratoxin A (OTA) is a mycotoxin that causes renal tumors in rats, particularly in males. 
The mechanism below the marked sex-difference sensitivities to OTA is still unknown. In 
previous studies performed in fed conditions (Vettorazzi et al. 2008) mature males presented 
a different kinetic profile than young and female rats. The objective of the present study was 
to evaluate the effect of fasting and the involvement of the male-specific protein alpha-2u-
globulin on OTA kinetics in mature F344 rats of both sexes. A 24h kinetic study in fasted 
conditions has been performed and compared with fed conditions. Food ingestion has been 
controlled during two months and the presence of alpha-2u-globulin in the urine has been 
analyzed with SDS-gradient mini-gel electrophoresis. 
Fasting tends to increase the maximum plasma concentrations and the rate of absorption. 
The relative bioavailability is significantly increased under fasted conditions only in males. 
Mature males consumed a higher amount of food but, as the OTA dose administered, it was 
proportional to body weight. The reason why the OTA bioavailability is more affected in 
presence of food only in males is unknown. Several possibilities, such as differences in 
gastric emptying, OTA-food interactions and the involvement of alpha-2u-globulin are 
discussed.  
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1. Introduction 
Ochratoxin A (OTA) is a mycotoxin produced by several species of Aspergillus and 
Penicillium which can contaminate a great variety of foodstuffs and to which humans are 
continuously exposed, although at very low doses. The main products contaminated with 
ochratoxin A are plant products such as cereals, coffee beans, beans, pulses and dried fruit 
(EFSA, 2006), but human exposure can also occur via the consumption of meat products 
from animals that have been fed with contaminated feed (NTP, 1989).  The target organ of 
OTA is the kidney, inducing renal toxicity in all mammalian species tested and renal tumors 
in rodents. However, a wide range of other toxic effects, including hepatotoxicity (Bendele et 
al., 1985), immunotoxicity (Alvarez et al., 2004), teratogenicity (Pfohl-Leszkowicz and 
Manderville, 2007) and neurotoxicity (Belmadani et al., 1998; Sava et al., 2006), has also 
been described. In farm animals, it is considered to be a possible aetiological factor of some 
nephropathies in pigs (O'Brien and Dietrich, 2005) and in chickens (Stoev et al., 2002). In 
humans, it has been related with the Balkan Endemic Nephropathy (BEN) and with increases 
in the incidence of urinary tract tumors (Pfohl-Leszkowicz et al., 2002), but there is a lack of 
epidemiological evidence. Based on the aforementioned, the International Agency for 
Research on Cancer (IARC) classified OTA as a possible human carcinogen (group 2B), 
supported by sufficient evidence of carcinogenicity in animals studies and inadequate 
evidence in humans (IARC, 1993).  A tolerable weekly intake (TWI) of 120 ng/kg b.w. has 
also been established by the European Food Safety Authority (EFSA, 2006).  
However, although OTA has been thoroughly studied, there is still a concern regarding its 
potential genotoxicity and its mechanism of action as a carcinogen. A point that still remains 
unclear is the marked difference in sex specificity of OTA carcinogenicity in rodents (Bendele 
et al., 1985; NTP, 1989). The incidence of tumors in male rats is much higher than in 
females, but the mechanisms underlying this difference of sensitivity to OTA toxicity and the 
question of whether this is relevant or not for humans has still not been resolved.  
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It is widely known that the main objective of toxicokinetic studies is to provide information on 
systemic exposure and its relationship to dose levels and toxicity. The inter-species 
differences in absorption, distribution, metabolism and excretion processes make it difficult to 
extrapolate animal data to predict human safety. With a better understanding of 
toxicokinetics and mechanisms of biological activity, it is possible to reduce the uncertainty 
regarding the extrapolation of animal toxicology data to predict human safety (Dixit et al., 
2003). Unfortunately, in the main carcinogenesis studies performed to date with both sexes 
(NTP, 1989; Castegnaro et al., 1998; Son et al., 2003), OTA plasmatic concentration was not 
measured. Therefore, the impact of the toxicokinetics in OTA carcinogenesis was impossible 
to evaluate and to compare between the two genders. Recently, a kinetic study comparing 
young F344 rats (10 weeks old) and mature rats (15 weeks old) of both sexes (Vettorazzi et 
al., 2009) was carried out in order to evaluate the impact of sex and age on OTA 
toxicokinetics after a single oral dose. For the purpose of mimicking the conditions of long-
term toxicological studies and natural exposure, the animals did not fast (fed conditions) 
before the single oral dose administered by gavage (0.5 mg/kg b.w. in NaHCO3 0.1 M pH 
7.4). This study showed a different kinetic profile in mature males, which presented a lower 
bioavailability and a higher apparent volume of distribution than in females and young rats. 
However, the apparent volume of distribution increased significantly with body weight. 
Therefore, the difference between genders obtained in this study could be related to male-
specific mechanisms or to weight, because these two factors are not independent: for a 
same age, males always weigh more than females.  
Even though administering OTA to animals under fed conditions was performed to approach 
long-term studies situation, it is known that food can alter bioavailability of substances by 
various means, including: delay gastric emptying, stimulate bile flow, change gastrointestinal 
pH, increase splanchnic blood flow, change luminal metabolism of a substance, and 
physically or chemically interact with the substance (FDA, 2002). Numerous kinetic studies 
have been performed in order to evaluate food-effect in different substances, especially in 
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pharmaceutical drugs. Some of the results obtained in these studies have been 
unpredictable, leading to a wide range of interactions that went from no effect to reduction, 
delay, increase or acceleration of the drug absorption (for a review see Welling, 1996). Even 
though the effect of standard laboratory diet in OTA absorption in rats has not been 
specifically studied, some studies have been performed in order to search for active 
adsorbents that would decrease OTA gastrointestinal absorption in animals (Huwig et al., 
2001; Avantaggiato et al., 2007; Denli et al., 2008). Aoudia et al. (2008) described a 
protective effect against OTA absorption in rats when micronized wheat fibres (MWF) were 
added to feed contaminated with the mycotoxin. The authors attributed this effect to the fact 
that some of the plant cell wall components would trap the mycotoxin in their matrix, 
preventing toxin absorption from the gastrointestinal tract and favouring its elimination by 
faeces.  
Another factor that may be involved in the kinetic differences between gender and age of rats 
is the presence of the male-rat-specific protein alpha-2u-globulin. The alpha-2u-globulin is a 
low molecular weight protein that is synthesized in the liver of males under androgenic 
control and reaches very high levels in plasma and urine of adult male rats. Many chemicals, 
such as d-limonene or 2,2,4-trimethylpentane, induce accumulation of the alpha-2u-globulin 
in the male kidney (for a review see Swenberg, 1993). This accumulation initiates a 
sequence of events that appears to lead to nephropathy and renal tumor formation (Rodgers 
and Baetcke, 1993). None of these chemicals have caused a similar nephropathy in female 
rats or in either sex of any other species (Swenberg, 1993). Even though it has been 
demonstrated that ochratoxin A kidney lesions are different from the alpha-2u-nephropathy in 
all characteristic points (Rasonyi et al., 1999) and that OTA also causes renal tumors in male 
mice (Bendele et al., 1985), a new concept involving this low protein in OTA toxicity has been 
published (Mantle and Nagy, 2008). These authors suggested that the alpha-2u-globulin may 
act as a specific OTA carrier that increases proximal tubule exposure to the mycotoxin in the 
male rat.  
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For all the above mentioned reasons, the objective of this study was to evaluate the possible 
factors that may be in the origin of the different kinetic profile obtained in fed mature male 
rats described in (Vettorazzi et al., 2009). The first aspect that needed to be studied is the 
markedly lower OTA bioavailability obtained in mature males. For this purpose, and in order 
to determine if there was an interaction with food, a 24h kinetic study in fasted conditions has 
been performed. Food ingestion in young and mature F344 rats of both sexes has also been 
controlled during two months. Finally, the presence of the male-specific protein alpha-2u-
globulin in the urine of all of the different groups of animals has been studied. 
2. Materials and methods 
2.1. Reagents  
OTA was purchased from Sigma (Steinheim, Germany). For the animal oral administration, 
OTA was dissolved in 0.1 M NaHCO3 (Sodium Hydrogen Carbonate powder. Riedel-deHaën, 
Seelze, Germany) and adjusted to pH 7.4 with HCl. OTA solutions were prepared in 
chemical safety cabinet and were always manipulated with double gloves and filtering masks 
FFP3. For the retro-orbital blood collection, animals were anesthetized with isoflurane 
(IsoFlo®, Veterinaria Esteve, Barcelona, Spain). All reagents used for the HPLC analysis 
were of pro-analysis grade. Sodium acetate and phosphoric acid were purchased from 
Panreac (Barcelona, Spain). Acetonitrile and methanol HPLC grade were obtained from 
Sigma Aldrich (Steinheim, Germany). The reagents used for OTA extraction and calibration 
standards were: absolute ethanol UV-IR-HPLC PAI and trichloroacetic acid 20% w/v, both 
from Panreac (Barcelona, Spain) and normal saline solution 0.9% from Braun (Barcelona, 
Spain). HPLC water from Millipore´s Milli-Q System was used throughout the analysis. 
The SDS-PAGE was performed on 10-15% gradient precast mini gels using SDS buffer 
strips (PhastGelTM, GE Healthcare, Uppsala, Sweden). Loading buffer (pH=8) was 40 mM 
Tris/HCl (Tris: PlusOne, Pharmacia Biotech, Buckinghamshire, UK), 4 mM EDTA (Sigma, St 
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Louis, USA), 10% SDS (PlusOne, Pharmacia Biotech, Uppsala, Sweden), 20% β-
mercaptoethanol (Sigma, St Louis, USA) and bromophenol blue sodium salt (Sigma, St 
Louis, USA). The coomassie stain used was Instant Blue® (Expedeon, Cambridge, UK). The 
positive control was male rat alpha-2u-globulin, same as used by Mantle and Nagy (2008). 
The molecular weight marker used was prepared from LMW-SDS marker kit (GE Healthcare, 
UK). 
2.2. Kinetic study 
2.2.1 Animals 
All the animal studies performed were approved by the Ethics Committee on Animal 
Experimentation of the University of Navarra (Spain). 
For the kinetic analysis, 15-week-old male (n=18) and female (n=18) Fisher 344 (F344) rats 
were used. All of the animals were purchased from Harlan (Horst, The Netherlands). On the 
day of arrival, the animals were weighed in order to assure that weight variation did not 
exceed ± 20% (OECD Guideline for testing of chemicals, Number 417). They were randomly 
housed in groups in polycarbonate cages with stainless steel covers so as to permit 
acclimatization to the environmental conditions (12h day/night cycle, temperature 22 ± 2ºC, 
relative humidity 55 ± 10%, standard diet “2014 Teklad Global 14% Protein Rodent 
Maintenance Diet” from Harlan Iberica Spain and water ad libitum) one week before 
commencing the study. On the day of administration, the animals were weighed (males: 
259.6±7.9 g and females: 169.9±6.6 g) in order to adjust the volume (1 mL/100 g b.w.) and 
the dose to be administered (0.5 mg/kg b.w. of OTA dissolved in NaHCO3 0.1M pH 7.4) to 
the animal weight. 
The experimental design was the same as in Vettorazzi et al. (2009) so as to allow 
comparison between the two studies. However, in this case, feed, but not water, was 
withdrawn 12h before the administration. Animals were administered a single oral OTA dose 
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(0.5 mg/kg b.w.) dissolved in NaHCO3 (0.1M pH 7.4) by oral gavage and were denied feed 
until 8 hours after the administration. In order to determine OTA concentrations in plasma at 
10 min, 30 min, 1h, 2h, 6h and 8h, blood from 3 animals per timepoint was collected from the 
retro-orbital sinus under isoflurane anesthesia. Blood from each animal was extracted only 
once and the extraction volumes chosen were volumes that would not affect volaemia (Diehl 
et al., 2001). At 12h and 24h (in order to obtain kidneys and livers for future experiments), 
plasma was obtained by decapitation (n=3 per endpoint).  
2.2.2 Determination of OTA in plasma by HPLC-FLD  
OTA quantification was performed with a method specifically validated for OTA determination 
in plasma of rats (Vettorazzi et al., 2008). After 30 min at room temperature, 250 µL of 
plasma were treated with 400 µL of ice-cold absolute ethanol and 50 µL of 20% 
trichloroacetic acid, vortexed for 1 min, mixed in a rotating shaker for 15 min and 
centrifugated at 6200 g at 4 ºC for 15 min. Supernatants were injected into the HPLC after 
having been filtered with 0.45 µm 13 mm Millex-HV syringe-driven polyvinylidene difluoride 
(PVDF) filter unit (Millipore, Bedford, USA). For blood samples with an expected high OTA 
concentration, supernatants were diluted (1/20) in a solution 1:5:8 (20% trichloroacetic acid: 
normal saline solution: absolute ethanol) before HPLC injection.  
The analysis was performed with an Agilent Technologies 1100 liquid chromatographic 
system equipped with a fluorescence detector (model G1321A) controlled by Chemstation 
3D software (Hewlett-Packard). OTA was analysed on a 5 µm (25 x 0.4 cm) Tracer Extrasil 
ODS2 column and a Tracer Extrasil ODS-2 precolumn, both from Teknokroma (Barcelona, 
Spain). The mobile phase was 29:29:42 (v/v) methanol-acetonitrile-sodium acetate (5mM 
acidified to pH 2.6 with phosphoric acid). The aqueous phases were filtered through a 0.45 
µm nylon membrane filter (Teknokroma, Barcelona, Spain). The injection volume was 100 µL 
and the flow rate was 1.5 mL/min. Chromatography was performed at 40ºC and monitored by 
9 
 
fluorescence detection (excitation at λ = 225 nm and emission at λ = 461 nm). The retention 
time for OTA in these conditions was 6.1 min. 
The LOD (limit of detection) and LOQ (limit of quantification) of this analytical method were 1 
µg/L and 8.4 µg/L, respectively. Recovery percentage was very efficient (96.0%) and the 
coefficient of variation (CV%) obtained in within- and between-day experiments were below 
10%. All of the OTA concentrations obtained in samples have been corrected by the 
recovery value. 
2.2.3 Kinetic analysis  
The concentration versus time data obtained from all of the animals in both groups was 
analyzed simultaneously using the software NONMEM version VI (Beal et al., 1989-2006). 
The 24h kinetic study in fasted conditions was performed in order to determine if the lower 
bioavailability obtained in fed mature males (Vettorazzi et al., 2009)  was due to food 
interaction or to another cause (for example, a different first pass effect). Thus, in order to 
compare the results between the two studies, the extraction timepoints were exactly the 
same. This implies that in the current study, the majority of the animals contributed to the 
pharmacokinetic data with only one observation, preventing thereby the estimation of both 
inter-animal and residual variability. Consequently, the naïve pool approach (Garrido et al., 
1999) was undertaken, in which all of the data is simultaneously analyzed, assuming it 
comes from a single animal. In this type of approach, only the parameters describing the 
mean pharmacokinetic profiles are estimated.  
Based on these limitations in the data, it was decided that the typical population estimates of 
the apparent volumes of distribution of the central and peripheral compartments (0.0276 and 
0.0158 L, respectively), the apparent total and inter-compartmental clearances (1.4 x 10-4 
and 8.2 x 10-4 L/h, respectively), the first order rate constant of absorption, KA, (1.24 h-1), and 
a relative bioavailability (F) of 1, all of which were obtained in the previous population 
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pharmacokinetic analyses (Vettorazzi et al., 2009), would be used during the modelling 
process. We decided to focus only in differences between fed and fasted conditions in the 
parameters related to the absorption process, KA, and F. 
The minimum value of the objective function provided by NONMEM, approximately equal to -
2xlog (likelihood) [-2LL], was used to study the significance of food effects on KA and F. For 
two nested models, a decrease in 3.84, or 6.63, points in -2LL for an extra parameter was 
considered significant at the 5 or 1% levels, respectively.  
2.3 Food consumption analysis  
Food intake data from OTA treated (single oral administration, 0.5 mg/kg b.w. in NaHCO3 
0.1M pH 7.4) F344 rats were analyzed in order to study the differences between sexes and 
ages (10 weeks old and 15 weeks old).  
According to the study design, animals (n=32) were housed in cages in groups of 4. Food 
intake of two cages of animals per experimental group (young males, young females, mature 
males and mature females) were controlled weekly for a period of 8 weeks (n= 2 cages x 8 
weeks= 16 data per experimental group). The average intake of food per animal and day was 
then calculated for each cage. 
The statistical analysis of food consumption data was performed with SPSS 15.0. The 
distribution of the data was checked for normality by the Shapiro-Wilk test and the 
homogeneity of the variance was verified by the Levene test. The results were analyzed by 
the two-way analysis of the variance (ANOVA), followed by Student´s t-test. The alpha level 
was 0.05. The between subject factors were: age (10 weeks old and 15 weeks old) and sex. 
However, it must be taken into account that the two groups of ages compared statistically 
correspond to two intervals of ages: from 10 weeks old to 18 weeks old for the rats that were 
10 weeks old at the beginning of the study, and the interval from 15 weeks old to 23 weeks 
old for the rats that were 15 weeks old at the beginning of the study. 
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Finally, in order to avoid the influence of the animal body weight in food consumption, the 
intake of food was normalized by 100 g of body weight, and another two-way ANOVA was 
conducted. 
2.4 Alpha-2u-globulin study 
In order to compare the presence of alpha-2u-globulin, urines of young male, young female, 
mature male and mature female F344 rats were analyzed. 
For the comparison between males and females at different ages (10 weeks old and 15 
weeks old), 24h collection of urine of non-treated rats were studied (n=2 per group) (gel 1). In 
order to compare the 10-week-old and 15-week-old OTA treated males (gel 2), urine 
collected during the first 24h after a single oral dose of OTA (0.5 mg/kg b.w. in NaHCO3 0.1 
M pH, 7.4) was analysed (n=3 per group). 
The alpha-2u-globulin analysis was performed using PhastSystemTM (Pharmacia). The urine 
samples were centrifugated for 5 min at 14000 g in order to remove impurities. Then, 5 µL of 
urine was diluted 1/2 with loading buffer and heated in thermoblock at 88ºC for 5 min. The 
alpha-2u-globulin control was diluted 1/10 with loading buffer and also heated at 88ºC for 5 
min. Then according to manufacturer´s protocol, 1 µL of each sample was loaded on the 
precast gradient 10-15% gel and run for 20 min. The gels were stained with Instant Blue® 
and the image was captured by the Syngene (Cambridge, UK) Diversity imaging system. 
3. Results  
After the single oral administration, OTA plasmatic levels were measurable in both sexes at 
all timepoints. Mature males presented a maximum observed OTA concentration (CMAXobs) 
of 4148.9 µg/L at 2h, while females reached a CMAXobs of 3674.4 µg/L 6 hours after the 
administration. Figure 1 shows the plasma concentration expressed as mean values of three 
observations per timepoint together with the corresponding standard deviation, in mature 
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males and females rats after a single oral administration of ochratoxin A in fasted conditions. 
Figure 1 also shows the predicted profiles corresponding to the model selected and 
parameters estimated from data obtained in young and mature rats after a single oral 
administration of ochratoxin A in fed conditions, where it was found that male mature rats 
showed a 34% decrease in relative bioavailability with respect to young males and females 
(young and mature) (Vettorazzi et al., 2009). Comparing the observed data under fasted 
conditions with the model predicted kinetic profile under fed conditions, it was observed that 
relative bioavailability in females is equivalent under both conditions. However, in the case of 
the males, F in fasted conditions is clearly increased with respect to the presence of food. 
With respect to F, fasted mature male and fasted mature female rats did not differ between 
themselves nor did they differ from young males and females (young and mature) in fed 
conditions (p >0.05). Therefore, the relative bioavailability of fasted mature males increased 
34% with respect to fed mature males. In addition, it appears that the rate of absorption is 
higher for both males and females in fasted conditions, since at early times after 
administration, observations appeared under-predicted by the model developed based on 
animal fed data. The value of KA resulted significantly higher (p <0.01) in fasted conditions 
(5.24 (15.3%) h-1) compared with the animals with free access to food (1.24 (14%) h-1) 
(Vettorazzi et al., 2009). This analysis could also identify a small lag time in the absorption 
process of 8.5 (4.1) min. 
The kinetic model selected for this study (solid lines in figure 1) has been obtained by 
updating the model previously selected in fed animals with the new estimates of KA, lag time, 
and considering F to be equal to one in both males and females. For comparison, the profiles 
obtained only with fed animals are superimposed as dashed lines in figure 1. 
Food ingestion data of rats of both sexes at different ages is presented in figure 2A. In order 
to evaluate the effect of age and sex on food ingestion, a two-way ANOVA was conducted. 
The two factors studied were age (10 weeks old and 15 weeks old) and sex. There was an 
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interaction between the two factors [F1 = 38.840, p < 0.001]. Further analysis showed that 
young animals ingested less food than mature animals in both sexes (Student´s t-test, p 
<0.001) and that for the same age, males consumed more food than females (Student´s t-
test, p <0.001). 
However, when food ingestion was normalized by 100 g of body weight (figure 2B) the 
differences between groups disappeared. After performing the two-way ANOVA, no 
interaction was found between the two groups [F1 = 0.808, p > 0.05] and no significant main 
effect was found for sex [F1 = 0.808, p > 0.05] or age [F1 = 0.600, p > 0.05]. 
With regard to the alpha-2u-globulin study, females of all ages did not eliminate alpha-2u-
globulin in urine, whereas alpha-2u-globulin it was present in the urine of males of all ages 
(figure 3: gel 1). In gel 2 (figure 3), urine from OTA-treated males of both ages were 
compared. No apparent differences between 10-week-old and 15-week-old males were 
observed. The differences of intensity of the bands were inversely correlated with the volume 
urinated (table of figure 3). 
4. Discussion 
The results obtained in the present study indicate that OTA relative bioavailability in mature 
males is much more influenced by food that in the case of females. The administration of 
OTA by oral gavage in fasted conditions, when comparing to fed conditions (Vettorazzi et al., 
2009), tend to increase the CMAXobs and the rate of absorption in all of the groups while not 
changing time at maximum observed concentration (Tmaxobs). These results indicate that 
food does not appear to delay the absorption window but seems to affect the extent of OTA 
absorption. However, only mature males in fed conditions showed a statistically significant 
difference (34% less relative bioavailability than the rest of the groups).  
After monitoring the food intake for 2 months in all of the groups, a statistical difference was 
detected among all groups, being the consumption in mature males > young males > mature 
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females > young females. This pattern of food consumption is inversely related with the OTA 
plasma levels describing the kinetic curves of each group in fed conditions:  mature males < 
young males < mature females < young females (Vettorazzi et al., 2009). However, only the 
kinetic curve of mature males was significantly different from the rest of the groups. When 
food consumption was normalized by 100 g of body weight, differences between the different 
groups disappeared. Taking into account that OTA has been administered in each case, 
adjusting the dose to body weight (0.5 mg/kg. b.w), the amount of OTA by grams of food in 
the GI tract of each animal should be the equivalent, and therefore the trapping effect that 
food may exert over the mycotoxin should be the same in both genders at the different ages. 
Therefore, the major difference regarding food consumption may lie in the higher absolute 
quantity of food ingested by mature males and/or in the anatomo-physiological differences in 
the GI tract between genders in mature animals. 
In general, a high volume of food normally delays gastric emptying (Shargel et al., 2005). It is 
also known that OTA is mainly absorbed in the upper part of the GI tract between stomach 
and proximal jejunum (Kumagai and Aibara, 1982; Pfohl-Leszkowicz and Manderville, 2007). 
If an anatomic absorption window exists within the GI tract in which OTA is efficiently 
absorbed (Shargel et al., 2005), it could be hypothesized that the differences in gastric 
emptying may account for the less efficient absorption profile observed in mature males in 
fed conditions. Normally, a delay in the gastric emptying slows the rate and the extent of the 
absorption because it also delays the time for a substance to reach the small intestine 
(Shargel et al., 2005). The results of this experiment indicate that this could also be 
happening with OTA.  
Moreover, a higher amount of food and a delay in the gastric emptying could also allow a 
larger contact in the stomach of OTA with the components of the food that may have a 
trapping effect towards the mycotoxin. One of the main ingredients of the pellet feed given to 
the animals is wheat and the total content of fibre in the pellets is 4.50% (2014 Teklad Global 
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14% Protein Rodent Maintenance Diet from Harlan). Aoudia et al. (2008) clearly 
demonstrated that micronized wheat fibers mixed in the animal diet act as active adsorbents. 
They demonstrated the protective effect of wheat fibers in terms of OTA concentration in 
plasma, kidney and liver. Thus, it seems plausible that a higher amount of food and/or a 
higher time in contact with food in the stomach, may lead to less OTA absorption. 
This coincides with the study performed by Mantle et al. (2005), where they observed that 
OTA had significantly less potency as a renal carcinogen in male rat when acquired as a 
dietary component than when given once daily by oral gavage (NTP, 1989). Furthermore, 
Miljkovic et al. (2003) also pointed out that the route of administration is a critical factor. 
These authors found that OTA plasma levels were lower when administered via diet than 
when administering the same doses (0.2 mg and 1mg OTA) by gavage, with the OTA plasma 
concentration being much lower in the animals receiving the higher dose by diet. Moreover, 
for the same dose of OTA, lesions were observed in the gavage-administered animals while 
there was an absence of pathology in the animals that were administered the equivalent 
dietary dose.  
The possible effect of the volume of food in the stomach coincides with the hypothesis that 
OTA is mainly passively absorbed from the GI (reviews Ringot et al. 2006; Pfohl-Leszkowicz 
and Manderville, 2007). However, the possibility of a carrier-mediated transport must not be 
discarded. Dietrich et al. (2005) suggested the presence of organic anion transporters with 
the capacity to transport OTA in the jejunum, but Berger et al. (2003) showed that these 
transporters were not implicated in OTA transport across Caco-2-cells. Another factor that 
may influence the OTA bioavailability is the finding that OTA is a substrate for the ATP-
Binding Cassette efflux-proteins MRP2 and BCRP in Caco-2-cells (Schrickx et al., 2006). 
These ATP-dependent membrane transporters facilitate secretion of xenobiotics outside the 
cell, thus, counteracting the absorption of toxic compounds (Schrickx et al., 2006). These 
authors also suggested that OTA bioavailability may also vary in the presence of food 
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because many food components are BCRP substrates. Moreover, Tanaka et al. (2005) found 
differences between genders in BCRP expression in different tissues of Sprague-Dawley 
rats. BCRP mRNA levels were high in male kidney, small intestine and large intestine, but 
were only statistically different from females in kidney. Even if these experiments were 
performed in another rat strain and the animals were much younger than the one used in our 
study, the influence of sex hormones in the expression of these receptors has been 
demonstrated.  
Other factors, such as changes in pH of the GI tract, stimulation of bile flow, increase in 
splanchnic blood flow or changes in the luminal metabolism that may be affected by the 
presence of food in the stomach must be also taken into account (FDA, 2002). However, 
even if the highest amount of food could be a cause, the exact reason of why food intake 
affects mature males much more than the rest of the groups needs to be obtained with 
mechanistic studies due to the lack of published data regarding anatomical and physiological 
differences between genders in rats.  
The experimental design in this study was performed in order to make it comparable with the 
study performed by Vettorazzi et al. (2009). For this reason, each animal only contributed 
with one datapoint, preventing the performance of a population approach modelling. 
Therefore, the kinetic analysis was focused only on differences between fed and fasted 
conditions for the parameters related to the absorption process (KA and F). We double-
checked the results obtained in this study by simultaneously analyzing them with the data 
obtained in Vettorazzi et al. (2009) using the same population modeling approach strategy as 
in the previous study. The results from this re-analysis are shown in figure 4 and the new 
parameter estimates are presented in table 1, together with the parameters obtained in the 
study previously performed with fed animals only (Vettorazzi et al., 2009). This re-analysis 
confirmed the lower bioavailability of mature males in fed conditions that could be attributable 
to a lower OTA absorption in the presence of food. The relationship between V/F and weight 
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was not significantly different from the one previously reported in fed animals (Vettorazzi et 
al., 2009).  
The final experiment performed in this study was to determine a possible influence of the 
specific male rat protein alpha-2u-globulin in the kinetics of OTA. As expected, the protein 
was not present in urine of females at any of the two ages (Swenberg, 1993). The protein 
was present in males of the two ages studied, showing that in this case, the presence of 
alpha-2u-globulin might not be the cause of the different kinetic profile obtained in mature 
males in (Vettorazzi et al., 2009). However, our combined pharmacokinetic findings need not 
conflict with a concept of augmented uptake of OTA into nephron epithelia by binding to an 
androgen-dependent α2u-globulin (Mantle and Nagy, 2008). The fact that fed mature males 
alone deviated from the general pattern of OTA pharmacokinetics could be consistent with 
glomerular filtration escape of some of the early-absorbed OTA carried on α2u-globulin during 
the first few hours after gavage dosing. In any case, our electrophoretic demonstration of 
marked gender difference in incidence of α2u-globulins in urine is only a distant qualitative 
reflection of the cryptic cycle of hepatic synthesis and fairly efficient renal salvage. The 
complexity of the <20 kDa urinary proteins of adult male rats has been revealed by two-
directional electrophoresis (Wait et al 2001) but  little is known of their dynamics as male rats 
become adult. Further studies, such as proteomics and kinetic studies in the kidney would be 
needed to consolidate the concept of alpha-2u-globulin involvement in OTA toxicity. 
In conclusion, the results obtained in this study clearly show that, when administered with 
food in the stomach, ochratoxin A bioavailability is lower, with the mature males being much 
more affected than females and young animals. This result highlights the need of taking into 
account the route of administration (gavage or dietary), the fast/fed conditions, the age and 
the gender of the animals used when interpreting the in vivo toxicological data generated to 
date. Furthermore, this finding might not only be important when studying OTA toxic effects 
in laboratory animals, but it could also be also relevant when estimating the OTA human 
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exposure due to the wide variety of foodstuff susceptible of being contaminated with OTA. 
The physiological changes of the GI tract and the trapping effect of the lumen content may 
vary depending on the food matrix in which the mycotoxin is present, and thereby affecting 
the mycotoxin bioavailability in different ways. Finally, it is also important to point out that the 
inter-gender differences and the influence of food observed in this study are not only relevant 
issues in ochratoxin A toxicity, but are also very interesting factors to be considered in any 
other chemical risk assessment. 
Appendix  
Supplementary data associated with this article, such as plasma concentrations raw data and 
kinetics parameters of each animal group, can be found in the online version. 
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Figure 1. Plasma OTA concentrations [expressed as mean values (solid circles) together 
with the corresponding standard deviation (vertical lines)] in mature male and female rats 
after a single oral administration of ochratoxin A (0.5 mg/kg b.w dissolved in NaHCO3 0.1M 
pH 7.4) in fasted conditions. Solid lines show model predictions based on optimized model 
parameters obtained in the current study. Dashed lines correspond to the predicted profiles 
of a model previously obtained in young and mature rats after a single oral administration of 
ochratoxin A in fed conditions (Vettorazzi et al., 2009).  
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Figure 2. Means and standard deviations of total food consumption (2A) and food 
consumption per 100 g of b.w.of animal (2B).  
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Figure 3. Coomassie-stained SDS-PAGE of urinary proteins of young and mature F 344 rats 
of both sexes performed in PhastGel gradient 10-15®.  a2u: alpha-2u-globulin standard. MW: 
molecular weight marker.  The table below shows the volumes of the 24h collection of urine 
of young and mature F344 rats of both sexes used for the alpha-2u-globulin analysis. 
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Figure 4. Evaluation of model performance of the selected population model. For each panel, 
open circles represent observations and lines show results from 1000 simulated profiles: 
solid 50th percentile, dashed, 5 and 95th percentiles. 
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Table 1. Population pharmacokinetic model parameters estimates of the selected model of 
fed animals (young and mature animals of both sexes) (left column) and of the re-analysis 
that included fasted animals (right columns). 
Parameter  Fed animals  Fed and Fasted 
animals 
KA (h‐1)  1.24 (14)  1.26 (12) 
V/F (L)  0.0276 (7)  0.0255 (5) 
CL/F (L x h‐1)  1.41 x 10‐4 (2)  1.4 x 10‐4 (2) 
Q/F (L x h‐1)  8.2 x 10‐4 (28)  1.15 x 10‐4 (15) 
VT /F(L)  0.0158 (10)  0.0181 (7)a 
F 
FMale&Maturet&Fed 
1*  
0.66 (2.4) 
1*  
0.64 (2.3) 
IAV_kA (%)  57 (24)  66 (24) 
IAV_V (%)  10 (36)  13 (36) 
IAV_F (%)  ‐  ‐ 
Corr(hV,hF)  ‐  ‐ 
Residual (%)  10 (16)  10.5 (16) 
 
Estimates are listed together with the corresponding coefficient of variation [CV(%)] in parenthesis. 
Inter-animal variability (IAV) is also expressed as CV(%). CL/F = apparent total plasma clearance; F, 
relative bioavailability; KA = first order rate constant of absorption; Q/F = apparent distribution 
clearance between the central and peripheral compartments; V/F, VT/F = apparent volumes of 
distribution of the central and peripheral compartments respectively.                         
*, arbritary value, not estimated; a parameter modeled as Vx (WGT/187) for (Vettorazzi et al., 2009) 
and V x (WGT/195.6) in this study. 
 
